Publications:

“The Evolution of Library Design: Crafting Smart Compound Collections for Phenotypic Screens.” K. Spear, S. Brown, Drug Discov. Today Technol. 23C, 63 (2017).

“In Vivo Phenotypic Drug Discovery: Applying a Behavioral Assay to the Discovery and Optimization of Novel Antipsychotic Agents.” L. Shao, U. Campbell, K. Fang, N. Powell, J. Campbell, P. Jones, T. Hanania, V. Alexandrov, I. Morganstern, E. Sabath, H. Zhong, T. Large, K. Spear; Med. Chem. Commun. 7, 1093 (2016).

Campbell RM, Dymshitz J, Eastwood BJ, Emkey R, Greenen DP, Heerding JM, Johnson D, Large TH, Littlejohn T, Montrose C, Nutter SE, Sawyer BD, Sigmund SK, Smith M, Weidner JR, and Zink RW.  Data Standardization for Results Management.  In: Sittampalam et al (editors). Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-2017.  https://ncats.nih.gov/expertise/preclinical/agm.  PMID: 22553865.

 

Invited Presentations:

2017                Drug Discovery USA Congress

2017                Harvard “Guppy Tank” Review Panel

2017                Non-academic  careers.  UCLA – Caltech MSTP Retreat

2016                Shanghai BioForum:  A Global Solution to the Crisis in Psychiatric Drug Discovery.

2016                Keystone Symposium on Modern Phenotypic Drug Discovery – Defining the Path Forward:  Discovery of Novel Psychiatric Drugs Using a Target-Agnostic, Systems Neurobiology Strategy.

2015                Inaugural Partners Health World Medical Innovation Forum – Neurosciences